Inogen

$53.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.65 (+1.24%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Inogen and other stocks, options, and ETFs commission-free!

About INGN

Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA. The listed name for INGN is Inogen, Inc Common Stock.

CEO
Nabil Shabshab
Employees
1,020
Headquarters
Goleta, California
Founded
2001
Market Cap
1.12B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
197.85K
High Today
$53.84
Low Today
$51.53
Open Price
$53.84
Volume
180.42K
52 Week High
$56.46
52 Week Low
$26.57

INGN News

BenzingaFeb 23

Earnings Outlook For Inogen

Inogen (NASDAQ:INGN) announces its next round of earnings this Wednesday, February 24. Here is Benzinga's everything-that-matters guide for this Wednesday's Q4

INGN Earnings

-$0.26
-$0.01
$0.24
$0.49
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.26 per share
Actual
-$0.23 per share
Replay Earnings Call

You May Also Like

VJET
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure